Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - iBio, Inc. | tm216632d1_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - iBio, Inc. | tm216632d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - iBio, Inc. | tm216632d1_ex31-1.htm |
| EX-10.8 - EXHIBIT 10.8 - iBio, Inc. | tm216632d1_ex10-8.htm |
| EX-10.7 - EXHIBIT 10.7 - iBio, Inc. | tm216632d1_ex10-7.htm |
| EX-10.6 - EXHIBIT 10.6 - iBio, Inc. | tm216632d1_ex10-6.htm |
| 10-Q - FORM 10-Q - iBio, Inc. | tm216632d1_10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of iBio, Inc. (the “Company”) for the quarterly period ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas F. Isett 3rd , Chairman and Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: | February 16, 2021 | /s/ Thomas F. Isett 3rd |
| Thomas F. Isett 3rd | ||
| Chairman and Chief Executive Officer | ||
| (Principal Executive Officer) |